Last reviewed · How we verify

NCT03248076

Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.

Status unknown Last updated 14 December 2017
What this trial tests

trial testing Fentanyl Citrate in Stress Reaction in 30 participants. Status unknown.

Timeline
1 April 2017
Primary endpoint
31 August 2018
10 October 2018

Quick facts

Lead sponsorGeorge Papanicolaou Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 April 2017
Primary completion31 August 2018
Estimated completion10 October 2018
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

George Papanicolaou Hospital

Who can join

Adults 18 to 32, female only, with Stress Reaction or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Opioids is known that produce not only analgesia but also hyperalgesia through activation of central glutaminergic system-GABA. At the same time, recently it was found that the main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1, causing ovarian hyperstimulation syndrome. This study aims to investigate if a single exposure to opioids is enough to produce activation of stress mechanism during oocyte retrieval.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fentanyl Citrate

Trials testing the same drug.

Other recruiting trials for Stress Reaction

Currently open trials in the same condition.

Other George Papanicolaou Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03248076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing